Liquid Biopsies and Non-Invasive Diagnostic Tools

Liquid biopsies represent a transformational shift in cancer diagnostics, offering a non-invasive way to detect tumors, monitor treatment response, and identify recurrence. By analyzing circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and exosomes in blood or other bodily fluids, clinicians can gain valuable insights into tumor genetics without requiring surgical tissue biopsies. These tools enable earlier detection, more frequent monitoring, and real-time evaluation of how tumors evolve under therapy. Liquid biopsies also support precision oncology by identifying actionable mutations that guide targeted treatments.

 

    Related Conference of Liquid Biopsies and Non-Invasive Diagnostic Tools

    December 08-09, 2025

    13th Euro Breast Cancer and Therapeutics

    Paris, France
    February 05-06, 2026

    11th World Conference on Breast and Cervical Cancer

    Paris, France
    February 19-20, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    February 19-20, 2026

    8th International Conference on Women Oncology

    Miami, USA
    March 09-10, 2026

    4th World Congress on Oral Cancer

    Singapore City, Singapore
    June 15-16, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    June 22-23, 2026

    16th World Congress on Breast Cancer

    Dubai, UAE
    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    September 29-30, 2026

    5th Experts Meeting on Cancer Medicine, Radiology & Treatment

    Aix-en-Provence, France

    Liquid Biopsies and Non-Invasive Diagnostic Tools Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in